Finzati - Logo
PDEX logo

Pro-Dex, Inc.

PDEX • Medical - Instruments & Supplies
$59.40
▲ +1.70 (+2.94%)
Current price
EarningsLatest report: Jun 30, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$197.02M
Growth
2.4%
Cash Flow
3/5
Trend
Mostly stable
Evidence
Stable or improving margins · 17.6%Positive revenue growth · 20.1%Positive free cash flow · 2.24Reasonable earnings multiple · 13.81Manageable debt level · 0.38
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Sep 4, 2026, 12:13 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$59.40
Change2.94%
Shares Out3.32M
Market Cap$197.02M
Enterprise Value$206.92M
52W Range23.47 - 69.86
Beta0.05
P/E14.42
P/S2.54
P/B4.14
P/FCF27.85
EV/Sales2.67

Investment DNA

How strong this company looks for long-term investors

80
out of 100
Business Quality
Margins, moat, returns
83/100
Financial Strength
Debt, cash, stability
75/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
72/100
Why this score▼
Stable or improving margins · 17.6%Positive revenue growth · 20.1%Positive free cash flow · 2.24Reasonable earnings multiple · 13.81Manageable debt level · 0.38Healthy liquidity · 4.1

Analyst view

Analyst sentiment and price target

PDEX
Analyst sentiment
Based on 1 analyst votes · 2026-10-21
100/100
Bullish
Bullish
1
Hold
0
Bearish
0

Company Overview

IPO: 8/7/1986
Industry: Medical - Instruments & Supplies
P/B i: 4.14
Debt / Equity i: 0.38
Operating Margin: 16.75%
Net Margin: 17.62%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.38
Current Ratio: 4.10
Quick Ratio: 2.45
Status: Good

Insider Transactions

Recent executive and insider activity

Domingo Angelita Rebamontan
Transaction: 07/23/2026
BUY
Change
+19
Price
$33.25
Filing
07/24/2026
Type
BUY
Domingo Angelita Rebamontan
Transaction: 03/16/2026
SELL
Change
-998
Price
$47.24
Filing
07/14/2026
Type
SELL
Van Kirk Richard Lee Jr
Transaction: 07/01/2026
SELL
Change
-5,279
Price
$62.74
Filing
07/06/2026
Type
SELL